Cindy Berejikian

Cindy Berejikian has 30 years of strategic and operational experience in biopharmaceutical drug development with executive roles in several start-ups including VP Program Management at Otonomy Inc. Ms. Berejikian has been a program operations executive consultant over the past 13 years for multiple start-up biopharmaceutical companies in which she has played an integral role in moving lead candidates from pre-IND to phase 2. This included acting as a key interface between each start-up and its vendors. Ms. Berejikian has also worked with notable academic Founders to launch successful newco’s such as Forty Seven Inc. Other accomplishments include partnering with CEOs and VCs to evaluate and optimize the portfolio of their existing small companies such as Adheron Therapeutics, resulting in pharma acquisition. Previously, Ms. Berejikian spent 16 years at Amgen Inc. which included Director, global program manager for various oncology products including the global BLA filing, approval and launch of Aranesp in Oncology. Ms. Berejikian received her BA in Pharmacology from the University of California at Santa Barbara, and her MBA from the University of California at Los Angeles.